{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:50:32Z","timestamp":1789426232427,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12020-020-02232-5","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T11:02:42Z","timestamp":1582628562000},"page":"368-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-079X","authenticated-orcid":false,"given":"Andreas","family":"Machens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Elwerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"2232_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMra1809315","volume":"381","author":"EE Eichler","year":"2019","unstructured":"E.E. Eichler, Genetic variation, comparative genomics, and the diagnosis of disease. N. Engl. J. Med. 381, 64\u201374 (2019)","journal-title":"N. Engl. J. Med."},{"key":"2232_CR2","doi-asserted-by":"publisher","first-page":"101274","DOI":"10.1016\/j.beem.2019.04.008","volume":"33","author":"A Machens","year":"2019","unstructured":"A. Machens, H. Dralle, Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer. Best. Pract. Res. Clin. Endocrinol. Metab. 33, 101274 (2019)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"2232_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/EJE-12-0919","volume":"168","author":"A Machens","year":"2013","unstructured":"A. Machens, K. Lorenz, C. Sekulla, W. H\u00f6ppner, K. Frank-Raue, F. Raue, H. Dralle, Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium. Eur. J. Endocrinol. 168, 307\u2013314 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"2232_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"S.A. Wells Jr, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G. Waguespack, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma, Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25, 567\u2013610 (2015)","journal-title":"Thyroid"},{"key":"2232_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/humu.23430","volume":"39","author":"A Machens","year":"2018","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Genotype-specific progression of hereditary medullary thyroid cancer. Hum. Mutat. 39, 860\u2013869 (2018)","journal-title":"Hum. Mutat."},{"key":"2232_CR6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1056\/NEJM199409293311302","volume":"331","author":"CJ Lips","year":"1994","unstructured":"C.J. Lips, R.M. Landsvater, J.W. H\u00f6ppener, R.A. Geerdink, G. Blijham, J.M. van Veen, A.P. van Gils, M.J. de Wit, R.A. Zewald, M.J. Berends, F.A. Beemer, J. Brouwers-Smalbraak, R.P. Jansen, H.K. Ploos van Amstel, T.J. van Vroonhoven, T.M. Vroom, Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N. Engl. J. Med. 331, 828\u2013835 (1994)","journal-title":"N. Engl. J. Med."},{"key":"2232_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00000658-199409000-00002","volume":"220","author":"SA Wells Jr","year":"1994","unstructured":"S.A. Wells Jr, D.D. Chi, K. Toshima, L.P. Dehner, C.M. Coffin, S.B. Dowton, J.L. Ivanovich, M.K. DeBenedetti, W.G. Dilley, J.F. Moley, J.A. Norton, H. Donis-Keller, Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann. Surg. 220, 237\u2013247 (1994)","journal-title":"Ann. Surg."},{"key":"2232_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"C. Eng, D. Clayton, I. Schuffenecker, G. Lenoir, G. Cote, R.F. Gagel, H.K. van Amstel, C.J. Lips, I. Nishisho, S.I. Takai, D.J. Marsh, B.G. Robinson, K. Frank-Raue, F. Raue, F. Xue, W.W. Noll, C. Romei, F. Pacini, M. Fink, B. Niederle, J. Zedenius, M. Nordenskj\u00f6ld, P. Komminoth, G.N. Hendy, H. Gharib, S.N. Thibodeau, A. Lacroix, A. Frilling, B.A.J. Ponder, L.M. Mulligan, The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276, 1575\u20131579 (1996)","journal-title":"JAMA"},{"key":"2232_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s002689900463","volume":"22","author":"H Dralle","year":"1998","unstructured":"H. Dralle, O. Gimm, D. Simon, K. Frank-Raue, G. G\u00f6rtz, B. Niederle, R.A. Wahl, B. Koch, S. Walgenbach, R. Hampel, M.M. Ritter, F. Spelsberg, A. Heiss, R. Hinze, W. H\u00f6ppner, Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J. Surg. 22, 744\u2013750 (1998). discussion 750\u2013751","journal-title":"World J. Surg."},{"key":"2232_CR10","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"A. Machens, P. Niccoli-Sire, J. Hoegel, K. Frank-Raue, T.J. van Vroonhoven, H.D. Roeher, R.A. Wahl, P. Lamesch, F. Raue, B. Conte-Devolx, H. Dralle, European Multiple Endocrine Neoplasia (EUROMEN) Study Group, Early malignant progression of hereditary medullary thyroid cancer. N. Engl. J. Med. 349, 1517\u20131525 (2003)","journal-title":"N. Engl. J. Med."},{"key":"2232_CR11","doi-asserted-by":"publisher","first-page":"T41","DOI":"10.1530\/ERC-17-0202","volume":"25","author":"A Machens","year":"2018","unstructured":"A. Machens, H. Dralle, Advances in risk-oriented surgery for multiple endocrine neoplasia type 2. Endocr. Relat. Cancer 25, T41\u201352 (2018)","journal-title":"Endocr. Relat. Cancer"},{"key":"2232_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1530\/EC-18-0157","volume":"7","author":"JS Mathiesen","year":"2018","unstructured":"J.S. Mathiesen, J.P. Kroustrup, P. Vestergaard, K. Stochholm, P.L. Poulsen, \u00c5.K. Rasmussen, U. Feldt-Rasmussen, S. Schytte, S.C. Londero, H.B. Pedersen, C.H. Hahn, B.D. Djurhuus, J. Bentzen, S. M\u00f6ller, M. Gaustadnes, M. Rossing, F.C. Nielsen, K. Brixen, A.L. Frederiksen, C. Godballe, Danish Thyroid Cancer Group (DATHYRCA), Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study. Endocr. Connect 7, 829\u2013839 (2018)","journal-title":"Endocr. Connect"},{"key":"2232_CR13","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1210\/jc.2009-2368","volume":"95","author":"A Machens","year":"2010","unstructured":"A. Machens, H. Dralle, Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J. Clin. Endocrinol. Metab. 95, 2655\u20132663 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2232_CR14","unstructured":"R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng, (eds) Pathology and genetics of tumours of endocrine organs 3rd edn. (World Health Organization, New York, NY, 2004)"},{"key":"2232_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SLA.0b013e3181ae333f","volume":"250","author":"A Machens","year":"2009","unstructured":"A. Machens, K. Lorenz, H. Dralle, Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels. Ann. Surg. 250, 305\u2013310 (2009)","journal-title":"Ann. Surg."},{"key":"2232_CR16","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1210\/jc.2015-1689","volume":"100","author":"A Machens","year":"2015","unstructured":"A. Machens, H. Dralle, Therapeutic effectiveness of screening for multiple endocrine neoplasia type 2A. J. Clin. Endocrinol. Metab. 100, 2539\u20132545 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2232_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-642-84749-3_9","volume":"125","author":"H Dralle","year":"1992","unstructured":"H. Dralle, G.F. Scheumann, J. Kotzerke, E.G. Brabant, Surgical management of MEN 2. Recent Results Cancer Res. 125, 167\u2013195 (1992)","journal-title":"Recent Results Cancer Res."},{"key":"2232_CR18","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.surg.2003.08.005","volume":"134","author":"M Brauckhoff","year":"2003","unstructured":"M. Brauckhoff, O. Gimm, P.N. Thanh, A. B\u00e4r, J. Ukkat, K. Brauckhoff, T. B\u00f6nsch, H. Dralle, Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy. Surgery 134, 1020\u20131027 (2003)","journal-title":"Surgery"},{"key":"2232_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jamcollsurg.2003.12.001","volume":"198","author":"L Yip","year":"2004","unstructured":"L. Yip, J.E. Lee, S.E. Shapiro, S.G. Waguespack, S.I. Sherman, A.O. Hoff, R.F. Gagel, J.F. Arens, D.B. Evans, Surgical management of hereditary pheochromocytoma. J. Am. Coll. Surg. 198, 525\u2013534 (2004)","journal-title":"J. Am. Coll. Surg."},{"key":"2232_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","volume":"15","author":"F Castinetti","year":"2014","unstructured":"F. Castinetti, X.P. Qi, M.K. Walz, A.L. Maia, G. Sans\u00f3, M. Peczkowska, K. Hasse-Lazar, T.P. Links, S. Dvorakova, R.A. Toledo, C. Mian, M.J. Bugalho, N. Wohllk, O. Kollyukh, L. Canu, P. Loli, S.R. Bergmann, J. Biarnes Costa, O. Makay, A. Patocs, M. Pfeifer, N.S. Shah, T. Cuny, M. Brauckhoff, B. Bausch, E. von Dobschuetz, C. Letizia, M. Barczynski, M.K. Alevizaki, M. Czetwertynska, M.U. Ugurlu, G. Valk, J.T. Plukker, P. Sartorato, D.R. Siqueira, M. Barontini, M. Szperl, B. Jarzab, H.H. Verbeek, T. Zelinka, P. Vlcek, S.P. Toledo, F.L. Coutinho, M. Mannelli, M. Recasens, L. Demarquet, L. Petramala, S. Yaremchuk, D. Zabolotnyi, F. Schiavi, G. Opocher, K. Racz, A. Januszewicz, G. Weryha, J.F. Henry, T. Brue, B. Conte-Devolx, C. Eng, H.P. Neumann, Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol. 15, 648\u2013655 (2014)","journal-title":"Lancet Oncol."},{"key":"2232_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.8898","volume":"2","author":"HPH Neumann","year":"2019","unstructured":"H.P.H. Neumann, U. Tsoy, I. Bancos, V. Amodru, M.K. Walz, A. Tirosh, R.J. Kaur, T. McKenzie, X. Qi, T. Bandgar, R. Petrov, M.Y. Yukina, A. Roslyakova, A.N.A. van der Horst-Schrivers, A.M.A. Berends, A.O. Hoff, L.A. Castroneves, A.M. Ferrara, S. Rizzati, C. Mian, S. Dvorakova, K. Hasse-Lazar, A. Kvachenyuk, M. Peczkowska, P. Loli, F. Erenler, T. Krauss, M.Q. Almeida, L. Liu, F. Zhu, M. Recasens, N. Wohllk, E.P.M. Corssmit, Z. Shafigullina, J. Calissendorff, S. Grozinsky-Glasberg, T. Kunavisarut, C. Schalin-J\u00e4ntti, F. Castinetti, P. Vlcek, D. Beltsevich, V.I. Egorov, F. Schiavi, T.P. Links, R.M. Lechan, B. Bausch, W.F. Young Jr, C. Eng; International Bilateral-Pheochromocytoma-Registry Group, Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy. JAMA Netw. Open 2, e198898 (2019). https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.8898","journal-title":"JAMA Netw. Open"},{"key":"2232_CR22","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1210\/jc.2018-01707","volume":"104","author":"LM Gruber","year":"2019","unstructured":"L.M. Gruber, R.P. Hartman, G.B. Thompson, T.J. McKenzie, M.L. Lyden, B.M. Dy, W.F. Young, I. Bancos, Pheochromocytoma characteristics and behavior differ depending on method of discovery. J. Clin. Endocrinol. Metab. 104, 1386\u20131393 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2232_CR23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/SLA.0b013e318237480c","volume":"254","author":"A Scholten","year":"2011","unstructured":"A. Scholten, G.D. Valk, D. Ulfman, I.H. Borel Rinkes, M.R. Vriens, Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann. Surg. 254, 1022\u20131027 (2011)","journal-title":"Ann. Surg."},{"key":"2232_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jso.23378","volume":"108","author":"KJ Rowland","year":"2013","unstructured":"K.J. Rowland, R.D. Chernock, J.F. Moley, Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening. J. Surg. Oncol. 108, 203\u2013206 (2013)","journal-title":"J. Surg. Oncol."},{"key":"2232_CR25","doi-asserted-by":"publisher","first-page":"E336","DOI":"10.1210\/jc.2012-3192","volume":"98","author":"A Machens","year":"2013","unstructured":"A. Machens, K. Lorenz, H. Dralle, Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. J. Clin. Endocrinol. Metab. 98, E336\u2013E345 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2232_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMra1806651","volume":"381","author":"HPH Neumann","year":"2019","unstructured":"H.P.H. Neumann, W.F. Young Jr, C. Eng, Pheochromocytoma and paraganglioma. N. Engl. J. Med. 381, 552\u2013565 (2019)","journal-title":"N. Engl. J. Med."},{"key":"2232_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/thy.2010.0336","volume":"21","author":"PK Magalh\u00e3es","year":"2011","unstructured":"P.K. Magalh\u00e3es, S.R. Antonini, F.J. de Paula, L.C. de Freitas, L.M. Maciel, Primary hyperparathyroidism as the first clinical manifestation of multiple endocrine neoplasia type 2A in a 5-year-old child. Thyroid 21, 547\u2013550 (2011)","journal-title":"Thyroid"},{"key":"2232_CR28","unstructured":"I. Schuffenecker, N. Ginet, D. Goldgar, C. Eng, B. Chambe, A. Boneu, C. Houdent, D. Pallo, M. Schlumberger, C. Thivolet, G.M. Lenoir, Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe d\u2019Etude des Tumeurs \u00e0 Calcitonine. J. Clin. Endocrinol. Metab. 83, 487\u2013491 (1998)"},{"key":"2232_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.neo.2014.09.002","volume":"16","author":"E Korpershoek","year":"2014","unstructured":"E. Korpershoek, B.J. Petri, E. Post, C.H. van Eijck, R.A. Oldenburg, E.J. Belt, W.Wde Herder, R.R. de Krijger, W.N. Dinjens, Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome. Neoplasia 16, 868\u2013873 (2014)","journal-title":"Neoplasia"},{"key":"2232_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/cen.12978","volume":"84","author":"A Machens","year":"2016","unstructured":"A. Machens, H. Dralle, Variability in penetrance of multiple endocrine neoplasia 2A with amino acid substitutions in RET codon 634. Clin. Endocrinol. 84, 210\u2013215 (2016)","journal-title":"Clin. Endocrinol."},{"key":"2232_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cen.13386","volume":"87","author":"L Mucha","year":"2017","unstructured":"L. Mucha, G. Leidig-Bruckner, K. Frank-Raue, T. Bruckner, M. Kroiss, F. Raue, German study group for rare thyroid cancer, Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades. Clin. Endocrinol. 87, 320\u2013326 (2017)","journal-title":"Clin. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02232-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-020-02232-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02232-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T19:09:14Z","timestamp":1614107354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-020-02232-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02232-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}